Comparative study on the efficacy of different dosage regimens of Ranibizumab in the treatment of choroid neovascularization secondary to pathological myopia

MLA

Meng-Ying Peng, and Qiong Zhou. “Comparative Study on the Efficacy of Different Dosage Regimens of Ranibizumab in the Treatment of Choroid Neovascularization Secondary to Pathological Myopia.” Guoji Yanke Zazhi, vol. 22, no. 11, Nov. 2022, pp. 1851–55. EBSCOhost, https://doi.org/10.3980/j.issn.1672-5123.2022.11.17.

APA

Meng-Ying Peng, & Qiong Zhou. (2022). Comparative study on the efficacy of different dosage regimens of Ranibizumab in the treatment of choroid neovascularization secondary to pathological myopia. Guoji Yanke Zazhi, 22(11), 1851–1855. https://doi.org/10.3980/j.issn.1672-5123.2022.11.17

Chicago

Meng-Ying Peng, and Qiong Zhou. 2022. “Comparative Study on the Efficacy of Different Dosage Regimens of Ranibizumab in the Treatment of Choroid Neovascularization Secondary to Pathological Myopia.” Guoji Yanke Zazhi 22 (11): 1851–55. doi:10.3980/j.issn.1672-5123.2022.11.17.